Ernexa's ERNA-101 combo shows tumor clearance in animal study
Go back to Ernexa's ERNA-101 combo shows tumor clearance in animal study| (NASDAQ: ERNA) | Delayed: 3.83 +0.07 (1.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.76 | 52 Week High | $ | |||
| Open | $3.79 | 52 Week Low | $ | |||
| Day High | $3.89 | P/E | N/A | |||
| Day Low | $3.79 | EPS | $ | |||
| Volume | 8,272 | |||||

